BioMarin to Highlight Breadth of Innovative Development Pipeline

At Analyst and Investor Day on December 10th in New York

CheckOrphan—December 10, 2014

BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) will host an Analyst and Investor Day from 8am (ET) to 1pm (ET) on Wednesday, December 10, 2014 at The Plaza Hotel. BioMarin management and external experts will provide an update to the investment community on the Company's development portfolio, which is focused on innovative therapies to treat rare and ultra-rare diseases.

External key opinion leaders scheduled to present include:

• Cathleen Raggio, M.D., Attending Orthopedic Surgeon, Co-Director, The Kathryn O. and Alan C. Greenberg Center for Skeletal Dysplasias at Hospital for Special Surgery, New York

Interested parties may access a live audio webcast and slides of the presentations via the investor section of the BioMarin website.  A replay of the meeting will be archived on the site for at least one week.